Irunin - instructions for use, doses, side effects, contraindications

Itraconazole is a triazole derivative.Synthetic antifungal agent of a wide spectrum of action. Disrupts the synthesis of ergosterol, which is an important component of the cell membrane of fungi.

Active for infections caused by yeast-like fungi and yeast: Candida spp. including C. albicans, C. glabrata and S. Krusei and others.

Pharmacokinetics:

With intravaginal administration, an effective local concentration of itraconazole is created. Systemic absorption is minimal.

Indications:Local treatment of vulvovaginal candidiasis (including recurrent).

Contraindications:

- Hypersensitivity to itraconazole and other components of the drug;

- Pregnancy (I trimester).

Carefully:

- Pregnancy II and III trimester (the drug can be used only if the expected benefit for a woman exceeds the potential risk to the fetus;

- lactation period (if itraconazole is needed, breastfeeding should be discontinued).

Dosing and Administration:

Intravaginal.

Vaginal tablets are led into the vagina once in the evening before going to bed, in a supine position on the back with slightly bent legs.

The course of treatment is 7-14 days.

Repeated treatment is possible after consultation with a doctor.

Side effects:

Rarely: itching, burning sensation in the vagina, skin rash in the area of the external genitalia, which do not require drug withdrawal.

Overdose:

The use of the drug in elevated doses does not cause any reactions and conditions that are life-threatening.

In case of unintended use of the drug (inside) it is necessary to wash the stomach and prescribe inside Activated carbon. There is no specific antidote.

Interaction:

Not installed.

Special instructions:

To prevent reinfection, simultaneous treatment of sexual partners is necessary.

During treatment it is recommended to abstain from sexual intercourse.

To prevent reinfection, you should follow the rules of hygiene.

If clinical signs of infection persist after completion of treatment, a second microbiological study should be conducted to confirm the diagnosis.

If an allergic reaction occurs, treatment should be discontinued. If necessary, the drug can be removed by washing the vagina with boiled water.

Effect on the ability to drive transp. cf. and fur:

The drug does not affect the performance of potentially hazardous activities,requiring concentration of attention and rapid psychomotor reactions (driving, etc.).

Form release / dosage:Vaginal tablets, 200 mg.

Packaging:

For 1 or 10 tablets in a contour acheive box or in a can of orange glass, or a polymer can.

Each jar or 1 circuit cell package, together with the instruction for use, is placed in a pack of cardboard.

Storage conditions:

In a dry, the dark place at a temperature of no higher than 25 ° C.

Keep out of the reach of children.

Shelf life:

2 years.

Do not use after the expiration date.

Terms of leave from pharmacies:On prescription

Registration number:LSR-002615/07

Date of registration:07.09.2007 / 05.10.2015

Expiration Date:Unlimited

The owner of the registration certificate:VEROPHARM SA VEROPHARM SA Russia

Manufacturer: & nbsp

VEROPHARM SA Russia

Representation: & nbspVEROPHARM, AO VEROPHARM, AO Russia

Information update date: & nbsp15.11.2017

Illustrated instructions

Instructions

Irunin® (Irunin®)